Pliant Therapeutics extends poison pill expiration to March 2027

PLIANT THERAPEUTICS, INC.

Extended stockholder rights agreement expiration from March 11, 2026 to March 11, 2027.
Amendment entered with Computershare Trust Company on March 3, 2026.
Company states the extension is not in response to any specific takeover offer.
Rights may still be earlier redeemed, exchanged or terminated per original terms.

item 1.01 item 3.03 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

PLIANT THERAPEUTICS, INC. issued securities.

Exact text from the filing

On March 3, 2026, Pliant Therapeutics, Inc. (the “Company”) and Computershare Trust Company, N.A., as rights agent (the “Rights Agent”), entered into an Amendment to Stockholder Rights Agreement (the “Amendment”), amending the Stockholder Rights Agreement, dated as of March 12, 2025, between the Company and the Rights Agent (the “Rights Agreement”). The Amendment changes the final expiration time of the Rights (as defined in the Rights Agreement) from 5:00 p.m., New York City time on March 11, 2026 to 5:00 p.m., New York City time on March 11, 2027.

View on SEC.gov

17 equity issuances filed in the last 30 days. Browse all equity issuances →

PLIANT THERAPEUTICS, INC. filing history →

Source: SEC EDGAR

accession 0001746473-26-000024

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.